Literature DB >> 10231440

Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.

C Cerini1, S Geider, B Dussol, C Hennequin, M Daudon, S Veesler, S Nitsche, R Boistelle, P Berthézène, P Dupuy, A Vazi, Y Berland, J C Dagorn, J M Verdier.   

Abstract

BACKGROUND: Urine is supersaturated in calcium oxalate, which means that it will contain calcium oxalate crystals that form spontaneously. Their size must be controlled to prevent retention in ducts and the eventual development of a lithiasis. This is achieved, in part, by specific inhibitors of crystal growth. We investigated whether promoters of crystal nucleation could also participate in that control, because for the same amount of salt that will precipitate from a supersaturated solution, increasing the number of crystals will decrease their average size and facilitate their elimination.
METHODS: Albumin was purified from commercial sources and from the urine of healthy subjects or idiopathic calcium stone formers. Its aggregation properties were characterized by biophysical and biochemical techniques. Albumin was then either attached to several supports or left free in solution and incubated in a metastable solution of calcium oxalate. Kinetics of calcium oxalate crystallization were determined by turbidimetry. The nature and efficiency of nucleation were measured by examining the type and number of neoformed crystals.
RESULTS: Albumin, one of the most abundant proteins in urine, was a powerful nucleator of calcium oxalate crystals in vitro, with the polymers being more active than monomers. In addition, nucleation by albumin apparently led exclusively to the formation of calcium oxalate dihydrate crystals, whereas calcium oxalate monohydrate crystals were formed in the absence of albumin. An analysis of calcium oxalate crystals in urine showed that the dihydrate form was present in healthy subjects and stone formers, whereas the monohydrate, which is thermodynamically more stable and constitutes the core of most calcium oxalate stones, was present in stone formers only. Finally, urinary albumin purified from healthy subjects contained significantly more polymers and was a stronger promoter of calcium oxalate nucleation than albumin from idiopathic calcium stone formers.
CONCLUSIONS: Promotion by albumin of calcium oxalate crystallization with specific formation of the dihydrate form might be protective, because with rapid nucleation of small crystals, the saturation levels fall; thus, larger crystal formation and aggregation with subsequent stone formation may be prevented. We believe that albumin may be an important factor of urine stability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231440     DOI: 10.1046/j.1523-1755.1999.00426.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Antiurolithiatic effect of the taraxasterol on ethylene glycol induced kidney calculi in male rats.

Authors:  Mahboubeh Yousefi Ghale-Salimi; Maryam Eidi; Nasser Ghaemi; Ramezan Ali Khavari-Nejad
Journal:  Urolithiasis       Date:  2017-11-30       Impact factor: 3.436

Review 2.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

3.  Stone former urine proteome demonstrates a cationic shift in protein distribution compared to normal.

Authors:  Ann M Kolbach-Mandel; Neil S Mandel; Brian R Hoffmann; Jack G Kleinman; Jeffrey A Wesson
Journal:  Urolithiasis       Date:  2017-03-17       Impact factor: 3.436

Review 4.  From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis.

Authors:  Johannes M Baumann; Beat Affolter
Journal:  World J Nephrol       Date:  2014-11-06

5.  Inhibition of calcium oxalate crystallization by commercial human serum albumin and human urinary albumin isolated from two different race groups: evidence for possible molecular differences.

Authors:  Allen L Rodgers; Priscilla D Mensah; Sylva L Schwager; Edward D Sturrock
Journal:  Urol Res       Date:  2006-12

6.  Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.

Authors:  Yung-Ching Chien; David L Masica; Jeffrey J Gray; Sarah Nguyen; Hojatollah Vali; Marc D McKee
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

7.  Alteration of urinary macromolecules by adsorption on surfaces, probably an important factor in urolithiasis.

Authors:  J M Baumann; B Affolter; U von Arx; M Noël
Journal:  Urolithiasis       Date:  2013-09-14       Impact factor: 3.436

8.  Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis.

Authors:  Guangwen Cao; Guang Yang; Terry L Timme; Takashi Saika; Luan D Truong; Takefumi Satoh; Alexei Goltsov; Sang Hee Park; Taoyan Men; Nobuyuki Kusaka; Weihua Tian; Chengzhen Ren; Hongyu Wang; Dov Kadmon; Wei Wen Cai; A Craig Chinault; Timothy B Boone; Allan Bradley; Timothy C Thompson
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

Review 9.  Human kidney stones: a natural record of universal biomineralization.

Authors:  Mayandi Sivaguru; Jessica J Saw; Elena M Wilson; John C Lieske; Amy E Krambeck; James C Williams; Michael F Romero; Kyle W Fouke; Matthew W Curtis; Jamie L Kear-Scott; Nicholas Chia; Bruce W Fouke
Journal:  Nat Rev Urol       Date:  2021-05-24       Impact factor: 14.432

10.  Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor.

Authors:  Rita Costa; Frederico Ferreira-da-Silva; Maria J Saraiva; Isabel Cardoso
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.